Species difference in the excretion routes of Ciprofol (HSK3486) in rats and humans: Contribution of hepatic transporters and renal UDP-glucuronosyltransferase enzymes
文献类型：期刊论文
| 作者 | Zhou, Yufan1,2; Guo, Zitao2; Meng, Jian2 ; Kang, Xinyao1,2; Zhang, Menglin1,2; Wang, Hong2; Gong, Hao2; Zhu, Qing2; Chen, Xiaoyan1,2
|
| 刊名 | DRUG METABOLISM AND DISPOSITION
 |
| 出版日期 | 2025-06-01 |
| 卷号 | 53期号:6页码:10 |
| 关键词 | Excretion Glucuronide metabolites Multidrug resistance protein Species differences UGT enzymes |
| ISSN号 | 0090-9556 |
| DOI | 10.1016/j.dmd.2025.100083 |
| 英文摘要 | The primary metabolic pathways of the anesthetic Ciprofol in both humans and rats are glucuronidation (M4) and 4-hydroxylation, followed by glucuronidation (M5-1). However, there are significant interspecies differences in their excretion routes. M4 and M5-1 are primarily excreted into the bile (61.4% of the dose) in rats, while they are mainly cleared through the kidneys (70.9% of the dose) in humans. This study aimed to elucidate the reasons for this discrepancy between humans and rats. The in vitro microsomal incubations revealed that Ciprofol could be metabolized by both human hepatic and renal UDP-glucuronosyltransferases (UGTs) but only by rat hepatic UGTs. The hepatocyte uptake assays showed that the organic anion transporting polypeptides were involved in the uptake of M4 and M5-1 into rat liver, not human liver. Further, only in sandwich-cultured rat hepatocytes did M4 and M5-1 exhibit significant biliary excretion potential. Vesicular transporter assays indicated that M4 and M5-1 are sensitive substrates of human/rat multidrug resistance protein (hMRP/rMrp) 2 and hMRP3. Considering their protein expression levels in the liver and intrinsic transport clearance, hMRP3 contributed more to the efflux of M4 and M5-1 than hMRP2 in humans, leading to a greater tendency to enter the blood circulation. Conversely, in rat liver, rMrp2-mediated efflux of M4 and M5-1 was the major driving force of their biliary excretion. Overall, our study showed that the differences in the protein expression and activity of hepatic hMRP3/rMrp3 and hMRP2/rMrp2, as well as renal UGT activities, led to species differences in the excretion routes of Ciprofol glucuronide metabolites. Significance Statement: This research characterized the interspecies differences in the excretion routes of the 2 major glucuronide-conjugated metabolites of Ciprofol (M4 and M5-1) in humans and rats. Bile excretion and urine excretion are the main excretion pathways in rats and humans, respectively. Our findings revealed that different transport activities and expression levels of hepatic human/rat multidrug resistance protein 3 and human/rat multidrug resistance protein 2, as well as different renal UDPglucuronosyltransferase enzyme activities, are underlying reasons responsible for the differences. (c) 2025 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. |
| WOS关键词 | EXPRESSION ; DRUG |
| 资助项目 | National Natural Science Foundation of China[82373939] |
| WOS研究方向 | Pharmacology & Pharmacy |
| 语种 | 英语 |
| WOS记录号 | WOS:001503675900001 |
| 出版者 | ELSEVIER SCIENCE INC |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/318156]  |
| 专题 | 新药研究国家重点实验室 |
| 通讯作者 | Chen, Xiaoyan |
| 作者单位 | 1.Univ Chinese Acad Sci, Beijing, Peoples R China 2.Chinese Acad Sci, State Key Lab Drug Res, Shanghai Inst Mat Med, Shanghai, Peoples R China |
| 推荐引用方式 GB/T 7714 | Zhou, Yufan,Guo, Zitao,Meng, Jian,et al. Species difference in the excretion routes of Ciprofol (HSK3486) in rats and humans: Contribution of hepatic transporters and renal UDP-glucuronosyltransferase enzymes[J]. DRUG METABOLISM AND DISPOSITION,2025,53(6):10. |
| APA | Zhou, Yufan.,Guo, Zitao.,Meng, Jian.,Kang, Xinyao.,Zhang, Menglin.,...&Chen, Xiaoyan.(2025).Species difference in the excretion routes of Ciprofol (HSK3486) in rats and humans: Contribution of hepatic transporters and renal UDP-glucuronosyltransferase enzymes.DRUG METABOLISM AND DISPOSITION,53(6),10. |
| MLA | Zhou, Yufan,et al."Species difference in the excretion routes of Ciprofol (HSK3486) in rats and humans: Contribution of hepatic transporters and renal UDP-glucuronosyltransferase enzymes".DRUG METABOLISM AND DISPOSITION 53.6(2025):10. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。